Lilly, Novo Sink on FDA List of Foreign GLP-1 Manufacturers

(Bloomberg) -ABD organizers, the raw materials they use to make copies of GLP-1 drugs that broke box office records after establishing the “green list ın of the foreign producers who produce the raw materials Eli Lilly & Co. And the shares of Novo Nordisk A/S fell.

The Food and Drug Administration said on Friday that he would publish a list of overseas suppliers who seem to have complied with the standards of the agency in order to prevent the importation of potentially dangerous versions of active ingredients used in drugs such as Wegovy and Mounjaro. Compound pharmacies use these raw materials to make their own versions of brand drugs.

“The agency is aware that some patients are turning to compound versions of these drugs that are not approved by FDA,” he said. The Green List contains active ingredients used in GLP-1 drugs produced in facilities that seem to be in accordance with the agency “to protect patients using these compound drugs”.

The list contains more than three dozens of manufacturers, but their names have been corrected. The agency said that active pharmaceutical components or raw materials known as APIs may be deducted when imported.

Lilly shares fell to 2.7% on Friday and Novo’s American deposit receipts fell to 2.5%.

Novo said in a statement, “It is very important to effectively apply this import warning of the FDA and take more precautions to protect patients from the security risks that arise by taking the original, non -standard API of the US, which have the potential to import or who have already the potential to import,”.

FDA’s action, “an important first step, but more should be done,” he said. The compounds imported large amounts of illegal thyzepathia, the active ingredient in Mounjaro, the drug, and said, “FDA and other regulators to do more to stop illegal compounds before more people hurt.”

News seems to have made a comprehensive but largely unsuccessful legal effort to prevent Novo and Lilly from selling alternative versions of the drugs of compounds. When Wegovy and Mounjaro were famine, the colliding knockouts multiplied when they opened a legal gap that facilitates the compounds.

These famine has ended since then, and brand companies claim that it is illegal to constantly joining its products. The components do not agree and medication are still present.

There are more stories like this Bloomberg.com